Hexagon Capital Partners’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-218	Closed	-$15.8K	–	583
2025 Q1	$15.8K	Sell	218 -242	-53%	-$17.3K	﹤0.01%	826
2024 Q4	$34.1K	Sell	460 -136	-23%	-$9.52K	0.01%	606
2024 Q3	$39.3K	Sell	596 -213	-26%	-$15.5K	0.01%	500
2024 Q2	$74.7K	Buy	809 +106	+15%	+$9.39K	0.02%	351
2024 Q1	$67.2K	Buy	703 +176	+33%	+$14.8K	0.01%	364
2023 Q4	$40.2K	Buy	527 +14	+3%	+$974	0.01%	461
2023 Q3	$35.5K	Hold	513	–	–	0.01%	429
2023 Q2	$48.4K	Hold	513	–	–	0.01%	371
2023 Q1	$42.4K	Hold	513	–	–	0.01%	389
2022 Q4	$38.3K	Hold	513	–	–	0.01%	411
2022 Q3	$42K	Sell	513 -254	-33%	-$24.4K	0.01%	421
2022 Q2	$73K	Hold	767	–	–	0.02%	307
2022 Q1	$90K	Hold	767	–	–	0.02%	291
2021 Q4	$99K	Hold	767	–	–	0.03%	269
2021 Q3	$87K	Hold	767	–	–	0.03%	268
2021 Q2	$79K	Buy	767 +39	+5%	+$3.68K	0.02%	277
2021 Q1	$60K	Sell	728 -3	-0.4%	-$254	0.02%	288
2020 Q4	$66K	Hold	731	–	–	0.02%	241
2020 Q3	$53K	Buy	+731	New	+$57K	0.02%	247